SG153698A1 - Composition and method for prevention and treatment of alzheimeræs disease - Google Patents
Composition and method for prevention and treatment of alzheimeræs diseaseInfo
- Publication number
- SG153698A1 SG153698A1 SG200719013-5A SG2007190135A SG153698A1 SG 153698 A1 SG153698 A1 SG 153698A1 SG 2007190135 A SG2007190135 A SG 2007190135A SG 153698 A1 SG153698 A1 SG 153698A1
- Authority
- SG
- Singapore
- Prior art keywords
- composition
- disease
- prevention
- treatment
- alzheimeræs
- Prior art date
Links
Abstract
COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE This invention presented is a composition and method for prevention and treatment of Alzheimer's disease, the composition comprising monacolins, anti-inflammation agents and anti- oxidant compounds is made by the method of the invention. The composition of the invention has effect on prevention and treatment of Alzheimer's disease without noticeable side effects caused to patients.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200719013-5A SG153698A1 (en) | 2007-12-26 | 2007-12-26 | Composition and method for prevention and treatment of alzheimeræs disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG200719013-5A SG153698A1 (en) | 2007-12-26 | 2007-12-26 | Composition and method for prevention and treatment of alzheimeræs disease |
Publications (1)
Publication Number | Publication Date |
---|---|
SG153698A1 true SG153698A1 (en) | 2009-07-29 |
Family
ID=40901930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200719013-5A SG153698A1 (en) | 2007-12-26 | 2007-12-26 | Composition and method for prevention and treatment of alzheimeræs disease |
Country Status (1)
Country | Link |
---|---|
SG (1) | SG153698A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019842A (en) * | 2019-12-31 | 2020-04-17 | 光明乳业股份有限公司 | Monascus purpureus and application thereof |
CN111117898A (en) * | 2019-12-31 | 2020-05-08 | 光明乳业股份有限公司 | Monascus purpureus and application thereof |
CN113424884A (en) * | 2021-05-08 | 2021-09-24 | 上海共得健康科技集团有限公司 | Method for preparing monascus tartary buckwheat tea by using high-temperature monascus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02303477A (en) * | 1989-05-19 | 1990-12-17 | Oriental Foods:Kk | Production of fruit vinegar |
WO2006027529A2 (en) * | 2004-09-03 | 2006-03-16 | Df3 | Method for obtaining fractions from bran cereals and fractions thus obtained |
US20070166321A1 (en) * | 2006-01-13 | 2007-07-19 | Bryant Villeponteau | Compositions and Methods for Reducing Cholesterol and Inflammation |
-
2007
- 2007-12-26 SG SG200719013-5A patent/SG153698A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02303477A (en) * | 1989-05-19 | 1990-12-17 | Oriental Foods:Kk | Production of fruit vinegar |
WO2006027529A2 (en) * | 2004-09-03 | 2006-03-16 | Df3 | Method for obtaining fractions from bran cereals and fractions thus obtained |
US20070166321A1 (en) * | 2006-01-13 | 2007-07-19 | Bryant Villeponteau | Compositions and Methods for Reducing Cholesterol and Inflammation |
Non-Patent Citations (1)
Title |
---|
RED MOLD RICE AMELIORATES IMPAIRMENT OF MEMORY AND LEARNING ABILITY IN INTRACERBROVENTRICULAR AMYLOID BETA-INFUSED RAT BY REPRESSING AMYLOID BETA ACCU * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019842A (en) * | 2019-12-31 | 2020-04-17 | 光明乳业股份有限公司 | Monascus purpureus and application thereof |
CN111117898A (en) * | 2019-12-31 | 2020-05-08 | 光明乳业股份有限公司 | Monascus purpureus and application thereof |
CN113424884A (en) * | 2021-05-08 | 2021-09-24 | 上海共得健康科技集团有限公司 | Method for preparing monascus tartary buckwheat tea by using high-temperature monascus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
MY151048A (en) | Use of flibanserin for the treatment of post-menopausal sexual desire disorders | |
HRP20130345T1 (en) | New therapeutic approaches for treating cmt and related disorders | |
ZA200604114B (en) | Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease | |
MX2010004494A (en) | Use of trkb antibodies for the treatment of respiratory disorders. | |
MX2009002920A (en) | Treating pain, diabetes, and disorders of lipid metabolism. | |
MX2009002921A (en) | Azetidinone derivatives for the treatment of disorders of the lipid metabolism. | |
EP2382176A4 (en) | Use of nitrogen-containing curcumin analogs for the treatment alzheimer's disease | |
EA019970B8 (en) | Imidazolidinedione derivatives | |
IS8505A (en) | (S) -2-N-propylamino-5-hydroxyetraline as D3 agonist | |
UY28473A1 (en) | NEW COMPOUNDS | |
MX2009000657A (en) | Compositions and methods for the treatment of mucositis. | |
MX2011012015A (en) | Treatment of mci and alzheimer's disease. | |
MX2008013196A (en) | 5-amido-2-carboxamide indoles. | |
CY1115725T1 (en) | UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS | |
WO2008104385A8 (en) | Method for the treatment of amyloidoses | |
TW200700071A (en) | Novel use | |
MX2009005351A (en) | Compounds useful for treating neurodegenerative disorders. | |
EA201001586A1 (en) | COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
MX2009004770A (en) | Carbamate compounds for use in treating depression. | |
PT1778837E (en) | Treatment of neurodegenerative diseases by the use of scd4 inhibitors | |
TW200640467A (en) | Compounds and uses thereof | |
SG153698A1 (en) | Composition and method for prevention and treatment of alzheimeræs disease | |
MX2009013482A (en) | [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases. |